Identification of Migraine Screener

Abstract

The Identification of Migraine Screener (ID Migraine) is a concise, three-item screening questionnaire designed to facilitate the rapid identification of individuals likely suffering from migraine in primary care settings. Developed by Lipton RB, et al. (2003), this instrument aims to simplify the diagnostic process for both the clinician and the patient.

The screener utilizes three simple yes/no questions pertaining to the patient’s headache experience over the preceding three months. Its primary function is to encourage patients suffering from recurrent headaches to engage in a discussion with their general practitioner, thereby facilitating timely and appropriate diagnosis and management of the condition.

Keywords

ID Migraine, Migraine, Headache, Screening Questionnaire, Primary Care, Diagnosis, Lipton RB.

Authors

Lipton RB, et al. (2003)

Purpose

The core purpose of the ID Migraine screener is to quickly and effectively distinguish between migraine headaches and other types of recurrent headaches (such as tension-type headache) in non-specialized clinical environments, particularly primary care. This instrument was developed in response to the recognized problem of high rates of undiagnosed or mismanaged migraine in the general population.

By using a minimal number of highly predictive questions, the instrument increases the likelihood that patients who meet the criteria for migraine, according to established diagnostic standards like the International Classification of Headache Disorders (ICHD), are referred for definitive diagnosis and specialized treatment. The test serves as a crucial first step in the clinical pathway for headache sufferers.

Construct

The ID Migraine screener measures the psychological and physiological construct of probable migraine headache. It is based on the identification of symptoms that are strongly correlated with the clinical presentation of migraine, particularly those related to functional impairment and associated autonomic symptoms.

The three items included in the scale are derived from extensive research identifying the most predictive symptoms of migraine when compared against ICHD criteria. The construct focuses on three critical domains: the presence of nausea or vomiting, the presence of light sensitivity (photophobia), and the degree of functional disability caused by the headache episode. An affirmative answer to two or three of these questions strongly suggests a migraine diagnosis.

Validity

The validity of the ID Migraine screener has been demonstrated through comparison with definitive clinical diagnosis, often using ICHD criteria as the gold standard. Early research established strong validity metrics, positioning it as a reliable tool for initial screening.

Specifically, studies have shown that the ID Migraine screener exhibits high sensitivity and acceptable specificity. In its original validation study, the test achieved a sensitivity of approximately 81% (correctly identifying those with migraine) and a specificity of about 75% (correctly ruling out migraine in those who do not have it). This performance confirms its utility as an effective screening tool to identify patients who warrant further diagnostic workup for migraine.

Reliability

Due to its brevity and binary (yes/no) response format focused on recent symptomatic history, the ID Migraine screener generally demonstrates strong reliability, particularly in terms of inter-rater reliability (since interpretation is minimal) and test-retest reliability over short periods. The questions pertain to the frequency and impact of headaches experienced over the previous three months, minimizing variability related to acute, transient episodes.

While specific psychometric coefficients for test-retest reliability are often reported in subsequent validation studies across different populations, the inherent simplicity and focus on core, chronic symptoms contribute to its consistent performance as a reliable quick screening measure for headache disorders.

Factor Analysis

Factor analysis is typically not performed or reported for the ID Migraine scale due to its structural design. As a three-item instrument designed to measure a single, overarching clinical construct (the likelihood of migraine presence), it is considered unidimensional. The items are weighted based on their predictive power rather than their contribution to separate latent factors.

The scale functions purely as a clinical screening index, where the cumulative score (number of positive responses) determines the probability of the patient meeting formal diagnostic criteria, rather than exploring underlying dimensions of the headache experience.

Instrument

Test Type: Screening Questionnaire

Format: Self-administered, three-item, binary (Yes/No) response format.

Language Available: Multiple languages (e.g., English, Dutch, Spanish, etc.)

Population Group: Clinical and General Population

Age Group: Adults

Population Details: Applicable to adults presenting in primary care or general practice settings complaining of recurrent headaches.

Test Methodology: Patients respond to three questions regarding their headache experiences over the past three months. A score of two or three positive responses is highly indicative of migraine.

The original explanatory form (Toelichtingsformulier) for this instrument can be accessed here: PDF Document Link.

Keywords

Clinical Screening, Photophobia, Nausea, Disability, Headache Assessment, Lipton RB, 2003, Self-report.

Authors

Author ORCID Identifier: N/A (Standardized ORCID not widely used in 2003)

Affiliation Email addresses: N/A (Not publicly specified for general correspondence)

Correspondence Address: Correspondence typically directed to Richard B. Lipton, MD, Montefiore Headache Center, Albert Einstein College of Medicine, NY, USA.

Permissions & Fee and Test Year

The ID Migraine screener is widely utilized in clinical practice and research due to its simplicity and public availability, often requiring no specific fee for standard clinical use. It is frequently employed as an initial screening tool in clinical trials and epidemiological studies.

Test Year: 2003 (Initial Publication and Validation)

Reference’s

• Lipton, R. B., Diamond, S., von Seggern, R. L., Kost, J., Ivanovic, K. M., & Reed, M. L. (2003). Development and validation of the ID Migraine screen for migraine diagnosis. Neurology, 61(5), 717-718.
• Headache Classification Committee of the International Headache Society (IHS). (2018). The International Classification of Headache Disorders, 3rd edition (ICHD-3). Cephalalgia, 38(1), 1–211.

Items of the Identification of Migraine Screener

IMPORTANT: The following scale items must be preserved in their original language and must not be changed in any way. Since the source content did not provide the specific Dutch items but referred to the instrument, the standard English items are provided here as the canonical structure of the screener.

1. Has a headache limited your ability to work, study or do what you needed to do for a day or more in the last three months? (Disability)
2. Have you felt nauseated or sick to your stomach because of your headache? (Nausea/Vomiting)
3. Has light bothered you when you had a headache (a lot more than when you don’t have a headache)? (Photophobia/Light Sensitivity)